HuGE Literature Finder
Records 1-25
|
Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms.
Leukemia research 2016 Apr 46 18-25. Gugliotta Luigi, Iurlo Alessandra, Gugliotta Gabriele, Tieghi Alessia, Specchia Giorgina, Gaidano Gianluca, Scalzulli Potito R, Rumi Elisa, Dragani Alfredo, Martinelli Vincenzo, Santoro Cristina, Randi Maria Luigia, Tagariello Giuseppe, Candoni Anna, Cattaneo Daniele, Ricco Alessandra, Palmieri Raffaele, Liberati Marina A, Langella Maria, Rago Angela, Bergamaschi Micaela, Monari Paola, Miglio Rossella, Santoro Umberto, Cacciola Rossella, Rupoli Serena, Mastrullo Lucia, Musto Pellegrino, Mazzucconi Maria Gabriella, Vignetti Marco, Cortelezzi Agostino, Vianelli Nicola, Martino Bruno, Stefano Valerio De, Passamonti Francesco, Vannucchi Alessandro M, |
|
Primary thrombophilia in Mexico: a single tertiary referral hospital experience.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2016 Jan . Lacayo-Leñero Dennis, Hernández-Hernández Darinel, Valencia-Martínez Andrés, Barrales-Benítez Olga, Vargas-Ruiz Angel |
|
Prevalence of JAK2V617F mutation in deep venous thrombosis patients and its clinical significance as a thrombophilic risk factor: Indian perspective.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 Sep 21 (6): 579-83. Singh Neha, Sharma Amit, Sazawal Sudha, Ahuja Ankur, Upadhyay Ashish, Mahapatra Manoranjan, Saxena Re |
|
Thrombophilia Profile in Budd-Chiari Syndrome and Splanchnic Vein Thrombosis: A Study from Western India.
The Journal of the Association of Physicians of India 2015 Sep 63 (9): 32-5. Sawant Prabha, Vashishtha Chitranshu, Nasa Mukesh, Parikh Pathik, Patel Jignesh, Agasti Anan |
|
Genetic determinants of tissue factor pathway inhibitor plasma levels.
Thrombosis and haemostasis 2015 Jul 114 (2): 245-57. Dennis J, Kassam I, Morange P-E, Trégouët D-A, Gagnon |
|
Influence of the JAK2 V617F Mutation and Inherited Thrombophilia on the Thrombotic Risk among Patients with Myeloproliferative Disorders.
Mædica 2015 Mar 10 (1): 27-32. Tevet Mihaela, Ionescu Razvan, Dragan Cornel, Lupu Anca Roxa |
|
Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia.
Annals of hematology 2014 Dec 93 (12): 2029-36. Chen Chih-Cheng, Gau Jyh-Pyng, Chou Hui-Ju, You Jie-Yu, Huang Cih-En, Chen Yi-Yang, Lung Jrhau, Chou Yi-Sheng, Leu Yu-Wei, Lu Chang-Hsien, Lee Kuan-Der, Tsai Ying-Hua |
|
Molecular characterization of Ph-negative myeloproliferative neoplasms in Ukraine.
Experimental oncology 2013 Sep 35 (3): 202-6. Mishcheniuk O Y, Kostukevich O M, Dmytrenko I V, Sholoyko V V, Prokopenko I M, Martina Z V, Pilipenko G V, Klymenko S |
|
Evaluation of the presence of hereditary and acquired thrombophilias in Brazilian children and adolescents with diagnoses of portal vein thrombosis.
Journal of pediatric gastroenterology and nutrition 2012 Nov 55 (5): 599-604. Ferri Priscila Menezes, Rodrigues Ferreira Alexandre, Fagundes Eleonora Druve Tavares, Xavier Sandra Guerra, Dias Ribeiro Daniel, Fernandes Ana Paula, Borges Karina Braga Gomes, Liu Shinfay Maximilian, de Melo Maria do Carmo Barros, Roquete Mariza Leitão Valadares, Penna Francisco Jo |
|
Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia.
The American journal of gastroenterology 2012 Oct 107 (10): 1579-85. Rebours Vinciane, Boudaoud Larbi, Vullierme Marie-Pierre, Vidaud Dominique, Condat Bertrand, Hentic Olivia, Maire Frédérique, Hammel Pascal, Ruszniewski Philippe, Lévy Philip |
|
Janus kinase (JAK) 2 V617F mutation in Asian Indians with cerebral venous thrombosis and without overt myeloproliferative disorders.
Journal of the neurological sciences 2012 Sep . De T, Prabhakar P, Nagaraja D, Christopher R |
|
The JAK2 V617F mutation in patients with cerebral venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2012 Jun 10 (6): 998-1003. Passamonti S M, Biguzzi E, Cazzola M, Franchi F, Gianniello F, Bucciarelli P, Pietra D, Mannucci P M, Martinelli |
|
JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients.
Blood 2011 Sep 118 (9): 2599-601. Panova-Noeva Marina, Marchetti Marina, Buoro Sabrina, Russo Laura, Leuzzi Annamaria, Finazzi Guido, Rambaldi Alessandro, Ottomano Cosimo, Ten Cate Hugo, Falanga An |
|
Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia.
Internal medicine journal 2011 May 41 (5): 408-15. Weston H, Cowell V, Grimmett K, Saal R, Jones M, Mills T, Gill D, Marlton P, Bird R, Mollee |
|
[Study on activated protein C resistance and disordered coagulation in patients with myeloproliferative neoplasms].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2011 Mar 32 (3): 187-90. Bai Jie, Xue Yang-ping, Xu Xian-hui, Zhang Lei, Tian Meng-su, Shen Lin, Zhang Hong-yun, Yang Ren-c |
|
Impact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women.
Journal of thrombosis and haemostasis : JTH 2011 Mar 9 (3): 496-501. Grandone E, Colaizzo D, Tiscia G, Vergura P, Cappucci F, Greco L, Margaglione M, Martinelli P, |
|
JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2011 49 (2): 267-71. Soko?owska Bo?ena, Nowaczy?ska Aleksandra, Bykowska Ksenia, Chocholska Sylwia, Wejksza Katarzyna, Walter-Croneck Adam, Gromek Tomasz, Kowalska Anna M, Kandefer-Szersze? Martyna, Dmoszy?ska An |
|
The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis.
Alimentary pharmacology & therapeutics 2010 Jun 31 (12): 1330-6. Orr D W, Patel R K, Lea N C, Westbrook R H, O'Grady J G, Heaton N D, Pagliuca A, Mufti G J, Heneghan M |
|
New real-time PCR-based method for the joint genotyping of JAK2 (V617F) with inherited thrombophilic F5 and F2 mutations.
Clinica chimica acta; international journal of clinical chemistry 2009 Dec 410 (1-2): 59-63. Martínez-Serra J, Maffiotte E, Gutierrez A, Durán M A, Amat J C, Besalduch |
|
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia.
Haematologica 2009 May 94 (5): 733-7. De Stefano Valerio, Za Tommaso, Rossi Elena, Fiorini Alessia, Ciminello Angela, Luzzi Claudia, Chiusolo Patrizia, Sica Simona, Leone Giusep |
|
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms.
British journal of haematology 2009 Mar 144 (6): 965-7. Za Tommaso, Fiorini Alessia, Rossi Elena, Ciminello Angela, Chiusolo Patrizia, Leone Giuseppe, De Stefano Valer |
|
JAK2V617F mutation in patients with portal vein thrombosis.
Digestive diseases and sciences 2008 Oct 53 (10): 2778-83. Bayraktar Yusuf, Harmanci Ozgur, Büyükasik Yahya, Shorbagi Ali Ibrahim, Sungur Aysegul Hasegeli, Boylu Cemaliye Akyerli, Gürgey Aytemiz, Balkanci Ferh |
|
Primary thrombophilia in México VII: the V617F mutation of JAK2 is not a frequent cause of thrombosis.
Hematology (Amsterdam, Netherlands) 2008 Aug 13 (4): 244-6. Garcés-Eisele Javier, González-Carrillo Martha L, Reyes-Núñez Virginia, Ruiz-Argüelles Guillermo |
|
JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients.
Mayo Clinic proceedings 2008 Apr 83 (4): 457-9. Pardanani Animesh, Lasho Terra L, Hussein Kebede, Schwager Susan M, Finke Cristy M, Pruthi Rajiv K, Tefferi Ayal |
|
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.
Journal of thrombosis and haemostasis : JTH 2007 Apr 5 (4): 708-14. De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P, Sica S, Leone |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 23, 2020
- Content source: